4.7 Article

Unique repertoire of anti-carbohydrate antibodies in individual human serum

期刊

SCIENTIFIC REPORTS
卷 10, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41598-020-71967-y

关键词

-

资金

  1. National Institutes of Health [P41GM103694]
  2. Swiss National Science Foundation [310030_162552, 310030_184757]
  3. Bern Center for Precision Medicine (BCPM)
  4. Swiss Cancer League/Swiss Cancer Research grants [KFS-3941-08-2016]
  5. Swiss National Science Foundation (SNF) [310030_184757, 310030_162552] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

Humoral immunity to pathogens and other environmental challenges is paramount to maintain normal health, and individuals lacking or unable to make antibodies are at risk. Recent studies indicate that many human protective antibodies are against carbohydrate antigens; however, little is known about repertoires and individual variation of anti-carbohydrate antibodies in healthy individuals. Here we analyzed anti-carbohydrate antibody repertoires (ACARs) of 105 healthy individual adult donors, aged 20-60(+) from different ethnic backgrounds to explore variations in antibodies, as defined by binding to glycan microarrays and by affinity purification. Using microarrays that contained>1,000 glycans, including antigens from animal cells and microbes, we profiled the IgG and IgM ACARs from all donors. Each donor expressed many ACAs, but had a relatively unique ACAR, which included unanticipated antibodies to carbohydrate antigens not well studied, such as chitin oligosaccharides, Forssman-related antigens, globo-type antigens, and bacterial glycans. We also saw some expected antibodies to ABO(H) blood group and alpha-Gal-type antigens, although these also varied among individuals. Analysis suggests differences in ACARs are associated with ethnicity and age. Thus, each individual ACAR is relatively unique, suggesting that individualized information could be useful in precision medicine for predicting and monitoring immune health and resistance to disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Digest the Sugar, Kill the Parasite: A New Experimental Concept in Treating Alveolar Echinococcosis

Junhua Wang, Stephan von Gunten, Guido Beldi, Denis Grandgirard, Stephen L. Leib, Bruno Gottstein

Summary: The study demonstrated that the parasite vesicular structure could be directly destroyed by adding galactosidases into the in vitro culture system, leading to the inability of the parasite metacestode vesicles to infect mice. Pretreatment of E. multilocularis metacestode with beta 1-3-galactosidase resulted in upregulated PD1 expression and lower IL-10 secretion in CD4(+) Teffs from inoculated mice, while there was no significant difference in PD1 and IL-10 expression levels in CD4(+) Teffs from mice inoculated with E. multilocularis metacestode pretreated with alpha 1-3,4,6-galactosidase.

PHARMACOLOGY (2021)

Article Allergy

Glycan-specific IgG anti-IgE autoantibodies are protective against allergic anaphylaxis in a murine model

Paul Engeroff, Kevin Plattner, Federico Storni, Franziska Thoms, Kayluz Frias Boligan, Lukas Muerner, Alexander Eggel, Stephan von Gunten, Martin F. Bachmann, Monique Vogel

Summary: The study demonstrates that glycan-specific IgG anti-IgE autoantibodies can downregulate serum IgE levels and anaphylactic activity, providing potential therapeutic implications for allergic diseases.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Tumor cells express pauci- and oligomannosidic N-glycans in glycoproteins recognized by the mannose receptor (CD206)

Kathrin Stavenhagen, Lisa C. Laan, Chao Gao, Akul Y. Mehta, Jamie Heimburg-Molinaro, Jonathan N. Glickman, Irma van Die, Richard D. Cummings

Summary: The macrophage mannose receptor (CD206, MR) shows high selectivity for specific types of pauci- and oligomannose N-glycans, which are often elevated in tumor cells, implying a potential role in tumor biology. The presence of MR glycoprotein ligands on cancer cells suggests a specific binding pattern that could be significant in tumor biology. Further analysis confirms the selective recognition of pauci- and oligomannose N-glycans by the MR, indicating a potential role in tumor biology.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Article Multidisciplinary Sciences

Differential recognition of oligomannose isomers by glycan-binding proteins involved in innate and adaptive immunity

Chao Gao, Kathrin Stavenhagen, Barbara Eckmair, Tanya R. McKitrick, Akul Y. Mehta, Yasuyuki Matsumoto, Alyssa M. McQuillan, Melinda S. Hanes, Deniz Eris, Kelly J. Baker, Nan Jia, Mohui Wei, Jamie Heimburg-Molinaro, Beat Ernst, Richard D. Cummings

Summary: The study investigates the recognition of oligomannose-type glycans in innate and adaptive immunity, developing a multifaceted approach to analyze glycan structures and create a comprehensive oligomannose microarray. The results show that different proteins exhibit unique specificity towards oligomannose motifs.

SCIENCE ADVANCES (2021)

Article Immunology

Therapeutic antibody glycosylation impacts antigen recognition and immunogenicity

Babette Wolf, Mateusz Piksa, Isabelle Beley, Agnes Patoux, Thierry Besson, Valerie Cordier, Bernd Voedisch, Patrick Schindler, Daniela Stoellner, Ludovic Perrot, Stephan von Gunten, Dominique Brees, Michael Kammueller

Summary: This study demonstrates the relevance of glycosylation in immune recognition of therapeutic antibodies, and the ability of defined glycan structures to modulate immunogenicity and anti-drug antibody responses. Glyco-engineering may be a useful strategy to reduce clinical immunogenicity and adverse events associated with antibodies.

IMMUNOLOGY (2022)

Editorial Material Pharmacology & Pharmacy

Diversification of IgA Antibody Specificities by Mild Chemical Modification?

Guy Gorochov, Stephan von Gunten

PHARMACOLOGY (2022)

Article Immunology

Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB

Morten Aagaard Nielsen, Kristian Juul-Madsen, John Stegmayr, Chao Gao, Akul Y. Mehta, Stinne Ravn Greisen, Tue Wenzel Kragstrup, Malene Hvid, Thomas Vorup-Jensen, Richard D. Cummings, Hakon Leffler, Bent Winding Deleuran

Summary: The study shows that Gal-3 binds to 4-1BB and forms large soluble 4-1BB/Gal-3 complexes that attach to mem4-1BB on the cell surfaces, leading to suppression of 4-1BBL's bioactivity. In rheumatoid arthritis patients, the complexes containing 4-1BB/Gal-3 were significantly reduced.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

N-glycosylation of mannose receptor (CD206) regulates glycan binding by C-type lectin domains

Kathrin Stavenhagen, Akul Y. Mehta, Lisa Laan, Chao Gao, Jamie Heimburg-Molinaro, Irma van Die, Richard D. Cummings

Summary: The macrophage mannose receptor (MR) is involved in immunity and maintaining homeostasis. The glycans within MR act as a regulatory switch by masking and unmasking self-ligands, controlling the receptor's activity.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Immunology

Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+T cells with high functional and metabolic capacities

Quentin Haas, Nikita Markov, Lukas Muerner, Viviana Rubino, Andrej Benjak, Monika Haubitz, Gabriela M. Baerlocher, Charlotte K. Y. Ng, Christian Munz, Carsten Riether, Adrian F. Ochsenbein, Hans-Uwe Simon, Stephan von Gunten

Summary: This study investigates the expression and function of inhibitory Siglec receptors in lymphocyte subsets. The researchers discover Siglec-7 as a glyco-immune checkpoint expressed on non-exhausted effector memory CD8+ T cells, regulating their functional and metabolic capacities. They also find that Siglec-7 polarization into the T cell immune synapse depends on sialoglycan interactions, which prevent actin polarization and effective T cell responses. Siglec-7 ligands are observed on leukemic stem cells and acute myeloid leukemia (AML) cells, suggesting the potential therapeutic role of Siglec-7 in T cell-driven disorders and cancer.

FRONTIERS IN IMMUNOLOGY (2022)

Article Pharmacology & Pharmacy

Modulation of Neutrophil Function by Recombinant Human IgG1 Fc Hexamer in the Endogenous K/BxN Mouse Model of Rheumatoid Arthritis

Ruqayyah J. Almizraq, Kayluz Frias Boligan, Bonnie J. B. Lewis, Selena Cen, Heather Whetstone, Rolf Spirig, Fabian Kasermann, Ian K. Campbell, Stephan von Gunten, Donald R. Branch

Summary: The study investigated the potential anti-inflammatory effect of rFc-mu TP-L309C on neutrophils in the K/BxN mouse model of rheumatoid arthritis. The results showed that rFc-mu TP-L309C treatment significantly ameliorated arthritis symptoms in K/BxN mice by reducing neutrophil infiltration and IL-1 beta production. This suggests that rFc-mu TP-L309C may be a potential therapeutic candidate for neutrophil-mediated autoimmune and inflammatory conditions.

PHARMACOLOGY (2023)

Article Cell Biology

Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naive Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts

Morten A. A. Nielsen, Ditte Koster, Akul Y. Y. Mehta, Kristian Stengaard-Pedersen, Pierre Busson, Peter Junker, Kim Horslev-Petersen, Merete Lund Hetland, Mikkel ostergaard, Malene Hvid, Hakon Leffler, Tue W. W. Kragstrup, Richard D. D. Cummings, Bent Deleuran

Summary: This study evaluated the clinical and pathogenic aspects of Gal-9 in rheumatoid arthritis (RA) and found that it plays a role in modulating synovial FLS activities and maintaining subclinical disease activity.
Letter Allergy

IgE glycosylation is essential for the function of omalizumab

Kevin Plattner, Gilles Augusto, Lukas Muerner, Stephan von Gunten, Lukas Jorg, Paul Engeroff, Martin. F. Bachmann, Monique Vogel

ALLERGY (2023)

Article Chemistry, Multidisciplinary

Heparan sulfate glycomimetics via iterative assembly of clickable disaccharides

Cangjie Yang, Yu Deng, Yang Wang, Chaoshuang Xia, Akul Y. Mehta, Kelly J. Baker, Anuj Samal, Putthipong Booneimsri, Chanthakarn Lertmaneedang, Seung Hwang, James P. Flynn, Muqing Cao, Chao Liu, Alec C. C. Zhu, Richard D. Cummings, Cheng Lin, Udayan Mohanty, Jia Niu

Summary: In this study, a new approach to HS glycomimetics was developed by iteratively assembling clickable disaccharide building blocks. The HS-mimetic oligomers with defined sulfation patterns were shown to bind protein FGF2 in a sulfation-dependent manner, indicating their potential application as alternatives to native HS in both fundamental research and disease models.

CHEMICAL SCIENCE (2023)

Review Pharmacology & Pharmacy

The Choice between Intravenous and Subcutaneous Immunoglobulins: Aspects for Consideration

Caroline von Achenbach, Giselle Hevia Hernandez, Stephan von Gunten

Summary: IVIG and SCIG are used to treat various immunodeficiencies and inflammatory conditions, with treatment decisions influenced by patient conditions, preferences, and economic factors. Understanding and comparing the two treatment modalities are crucial for optimal therapeutic options.

PHARMACOLOGY (2022)

暂无数据